These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Transient PPI responsive esophageal eosinophilia may be a clinical sub-phenotype of pediatric eosinophilic esophagitis. Dohil R, Newbury RO, Aceves S. Dig Dis Sci; 2012 May; 57(5):1413-9. PubMed ID: 22134787 [Abstract] [Full Text] [Related]
4. Expanding the paradigm of eosinophilic esophagitis: mast cells and IL-9. Wang YH, Hogan SP, Fulkerson PC, Abonia JP, Rothenberg ME. J Allergy Clin Immunol; 2013 Jun; 131(6):1583-5. PubMed ID: 23726533 [No Abstract] [Full Text] [Related]
5. Increased numbers of eosinophils, rather than only etiology, predict histologic changes in patients with esophageal eosinophilia. Sridhara S, Ravi K, Smyrk TC, Kita H, Kephart GM, Weiler CR, Katzka DA. Clin Gastroenterol Hepatol; 2012 Jul; 10(7):735-41. PubMed ID: 22289868 [Abstract] [Full Text] [Related]
8. Tryptase staining of mast cells may differentiate eosinophilic esophagitis from gastroesophageal reflux disease. Dellon ES, Chen X, Miller CR, Fritchie KJ, Rubinas TC, Woosley JT, Shaheen NJ. Am J Gastroenterol; 2011 Feb; 106(2):264-71. PubMed ID: 20978486 [Abstract] [Full Text] [Related]
9. Esophageal mast cells may be associated with the perception of symptoms in patients with eosinophilic esophagitis. Kanamori A, Tanaka F, Takashima S, Sawada A, Ominami M, Nadatani Y, Fukunaga S, Otani K, Hosomi S, Kamata N, Nagami Y, Taira K, Watanabe T, Fujiwara Y. Esophagus; 2023 Apr; 20(2):333-341. PubMed ID: 36342564 [Abstract] [Full Text] [Related]
10. Atopic and non-atopic eosinophilic oesophagitis are distinguished by immunoglobulin E-bearing intraepithelial mast cells. Mulder DJ, Mak N, Hurlbut DJ, Justinich CJ. Histopathology; 2012 Nov; 61(5):810-22. PubMed ID: 22978418 [Abstract] [Full Text] [Related]
19. Expression of CD25, mast cell markers and T-cell markers in eosinophilic esophagitis. Htoo A, Qualia CM, George R, Arker SH, Subasi NB, Lee H, Chung L, Chen A. Ann Diagn Pathol; 2024 Jun; 70():152287. PubMed ID: 38479198 [Abstract] [Full Text] [Related]
20. Vasoactive Intestinal Peptide Receptor, CRTH2, Antagonist Treatment Improves Eosinophil and Mast Cell-Mediated Esophageal Remodeling and Motility Dysfunction in Eosinophilic Esophagitis. Yadavalli CS, Upparahalli Venkateshaiah S, Verma AK, Kathera C, Duncan PS, Vaezi M, Paul RJ, Mishra A. Cells; 2024 Feb 06; 13(4):. PubMed ID: 38391908 [Abstract] [Full Text] [Related] Page: [Next] [New Search]